The slip
PARKINSON RECEIPTno. 7989
23 Oct 2026, 22:37 UTColigodendrocytes, braak
predictionZNF638 in oligodendrocytes tracks Braak Lewy-body stage
registered28923f6018a02334
discovery-0.07 p=0.857 n=9
replication+0.32 p=0.407 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho -0.07, p 0.857)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECT0f09387f26ab27fc842ba01c…
follows 6195f0ef0050…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 7989: ZNF638 in oligodendrocytes, braak
- power
- full sample +0.06 (p 0.807, n 18), 95% CI -0.42 to +0.51. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.09 (p 0.709, n 18). does not hold up.
- composition
- oligodendrocytes share of nuclei vs axis +0.03 (p 0.915); controlling for it: +0.23 (p 0.360, n 18). could be the mix.
- skeptic
- leave-one-out range -0.06 to +0.16, sign flips 4; without severely affected donors +0.06 (p 0.807, n 18). fragile.
- cell type
- strongest in microglia: -0.75 (p 3.1e-4, n 18) vs +0.06 in oligodendrocytes. proposing microglia.
- axis
- no measure beats "tracks Braak Lewy-body stage" for ZNF638 in oligodendrocytes.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up ZNF638 · microglia · braak: substantia nigra, an independent cohort (Parkinson's or LBD vs controls) +0.65 p 0.021 (needs p < 2.7e-4)